FRANKLIN STREET ADVISORS INC /NC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 187 filers reported holding PDL BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 2.92 and the average weighting 0.0%.

Quarter-by-quarter ownership
FRANKLIN STREET ADVISORS INC /NC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2018$53,000
+12.8%
20,0000.0%0.01%0.0%
Q2 2018$47,000
-20.3%
20,0000.0%0.01%
-22.2%
Q1 2018$59,000
+7.3%
20,0000.0%0.01%
+12.5%
Q4 2017$55,000
-27.6%
20,000
-11.1%
0.01%
-33.3%
Q3 2017$76,000
+35.7%
22,5000.0%0.01%
+20.0%
Q2 2017$56,000
+9.8%
22,5000.0%0.01%
+11.1%
Q1 2017$51,000
+6.2%
22,5000.0%0.01%
+12.5%
Q4 2016$48,000
-36.0%
22,5000.0%0.01%
-42.9%
Q3 2016$75,000
-36.4%
22,500
-40.0%
0.01%
-36.4%
Q2 2016$118,000
-11.3%
37,500
-6.2%
0.02%
-15.4%
Q1 2016$133,0000.0%40,000
+6.7%
0.03%0.0%
Q4 2015$133,000
-29.6%
37,5000.0%0.03%
-29.7%
Q3 2015$189,000
-21.6%
37,5000.0%0.04%
-14.0%
Q2 2015$241,000
-8.7%
37,5000.0%0.04%
-10.4%
Q1 2015$264,000
-8.7%
37,5000.0%0.05%
-12.7%
Q4 2014$289,000
+3.2%
37,5000.0%0.06%
+3.8%
Q3 2014$280,000
-22.9%
37,5000.0%0.05%
-23.2%
Q2 2014$363,000
+16.3%
37,5000.0%0.07%
+11.3%
Q1 2014$312,000
-1.3%
37,5000.0%0.06%
-3.1%
Q4 2013$316,000
+5.7%
37,5000.0%0.06%
-4.5%
Q3 2013$299,000
+3.5%
37,5000.0%0.07%
-5.6%
Q2 2013$289,00037,5000.07%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2017
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders